ARMGO Pharma

Armgo Pharma

Biotechnology, 923 Saw Mill River Road, Ardsley, New York, 10502, United States, 1-10 Employees

armgo.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +12*********

Who is ARMGO PHARMA

ARMGO is a privately owned, venture-backed, biotech company that is developing small molecule drugs that repair leaky Ryanodine Receptor (RyR) calcium channels associated with human disea...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ARMGO PHARMA

ARMGO Pharma Org Chart and Mapping

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding ARMGO Pharma

Answer: ARMGO Pharma's headquarters are located at 923 Saw Mill River Road, Ardsley, New York, 10502, United States

Answer: ARMGO Pharma's phone number is +12*********

Answer: ARMGO Pharma's official website is https://armgo.com

Answer: ARMGO Pharma's revenue is $1 Million to $5 Million

Answer: ARMGO Pharma's SIC: 2834

Answer: ARMGO Pharma's NAICS: 325412

Answer: ARMGO Pharma has 1-10 employees

Answer: ARMGO Pharma is in Biotechnology

Answer: ARMGO Pharma contact info: Phone number: +12********* Website: https://armgo.com

Answer: ARMGO is a privately owned, venture-backed, biotech company that is developing small molecule drugs that repair leaky Ryanodine Receptor (RyR) calcium channels associated with human diseases. Our primary focus is on two orphan diseases: the life-threatening cardiac disease Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), and the severe muscle disease RYR1-Related Myopathy (RYR1-RM). These two conditions occur due to genetic mutations in the RYR gene: RYR1 in RYR1-RM, and RYR2 in most CPVT cases. ARMGO’s molecules, termed Rycals® are designed to repair leaky RyR channels. Since the cause of the symptoms is abnormal calcium leak due to these mutations, Rycals hold the promise of disease-modifying therapy for these two orphan genetic diseases.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access